ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 156 filers reported holding ENANTA PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.10 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $5,000 | 0.0% | 90 | -18.9% | 0.00% | – |
Q2 2022 | $5,000 | -44.4% | 111 | -16.5% | 0.00% | – |
Q1 2022 | $9,000 | +50.0% | 133 | +25.5% | 0.00% | – |
Q3 2021 | $6,000 | +50.0% | 106 | +11.6% | 0.00% | – |
Q2 2021 | $4,000 | -42.9% | 95 | -29.6% | 0.00% | – |
Q1 2021 | $7,000 | +16.7% | 135 | -6.2% | 0.00% | -100.0% |
Q4 2020 | $6,000 | 0.0% | 144 | +4.3% | 0.00% | – |
Q3 2020 | $6,000 | +200.0% | 138 | +360.0% | 0.00% | – |
Q2 2020 | $2,000 | -75.0% | 30 | -76.4% | 0.00% | – |
Q4 2019 | $8,000 | -61.9% | 127 | -63.7% | 0.00% | -100.0% |
Q3 2019 | $21,000 | -94.3% | 350 | -92.0% | 0.00% | -96.2% |
Q2 2019 | $368,000 | +214.5% | 4,358 | +257.8% | 0.03% | +188.9% |
Q1 2019 | $117,000 | -5.6% | 1,218 | -30.6% | 0.01% | -18.2% |
Q4 2018 | $124,000 | -22.0% | 1,755 | -5.5% | 0.01% | -8.3% |
Q3 2018 | $159,000 | -99.9% | 1,857 | -19.9% | 0.01% | -47.8% |
Q2 2018 | $268,541,000 | +315830.6% | 2,317 | +123.4% | 0.02% | +187.5% |
Q1 2018 | $85,000 | +28.8% | 1,037 | -7.7% | 0.01% | +33.3% |
Q4 2017 | $66,000 | +46.7% | 1,124 | +18.3% | 0.01% | +20.0% |
Q3 2017 | $45,000 | +650.0% | 950 | +512.9% | 0.01% | +400.0% |
Q2 2017 | $6,000 | +200.0% | 155 | +124.6% | 0.00% | – |
Q1 2017 | $2,000 | – | 69 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Krensavage Asset Management, LLC | 511,186 | $43,686,000 | 11.23% |
GREAT POINT PARTNERS LLC | 210,400 | $17,981,000 | 2.80% |
ARMISTICE CAPITAL, LLC | 456,000 | $38,970,000 | 2.34% |
Matarin Capital Management, LLC | 210,208 | $17,964,376,000 | 1.16% |
Sapphire Star Partners LP | 8,168 | $698,000 | 0.70% |
Granahan Investment Management | 103,320 | $8,830,000 | 0.48% |
FARALLON CAPITAL MANAGEMENT LLC | 867,500 | $74,137,000 | 0.44% |
361 CAPITAL LLC | 19,040 | $1,627,000 | 0.35% |
ALGERT GLOBAL LLC | 17,922 | $1,532,000 | 0.33% |
AlphaMark Advisors, LLC | 9,310 | $796,000 | 0.32% |